Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Lee Johnson

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Journal of Palliative Medicine|February 28, 2006
Accounting for missing data in end-of-life researchPaula Diehr, Laura Lee Johnson
Statistics in Medicine|March 7, 2012
The statistical challenges in clinical studies. PrefaceXiao-Hua Zhou, Laura Lee Johnson
Archives of Internal Medicine|September 20, 2006
Insomnia, trouble sleeping, and complementary and alternative medicine: Analysis of the 2002 national health interview survey dataNancy J Pearson, Laura Lee Johnson, Richard L Nahin
Journal of Clinical Epidemiology|October 15, 2005
Methods for incorporating death into health-related variables in longitudinal studiesPaula Diehr, Laura Lee Johnson, Donald L Patrick, et al.
Cancer|October 22, 2025
Assessing tolerability of cancer therapeutics: A regulatory perspective from the FDA Oncology Center of ExcellenceVishal Bhatnagar, Laura Lee Johnson, Mallorie H Fiero, et al.
The New England Journal of Medicine|November 3, 2020
Withdrawing Approval of Makena - A Proposal from the FDA Center for Drug Evaluation and ResearchChristina Y Chang, Christine P Nguyen, Barbara Wesley, et al.
Integrative Cancer Therapies|August 2, 2006
Tai chi chuan: mind-body practice or exercise intervention? Studying the benefit for cancer survivorsPatrick Mansky, Tim Sannes, Dawn Wallerstedt, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2005
Gene-specific methylation and subsequent risk of colorectal adenomas among participants of the polyp prevention trialKaren Woodson, Daniel J Weisenberger, Mihaela Campan, et al.
Genes, Chromosomes & Cancer|August 23, 2005
beta-Catenin splice variants and downstream targets as markers for neoplastic progression of esophageal cancerMark J Roth, Nan Hu, Laura Lee Johnson, et al.
Cancer Causes & Control : CCC|April 2, 2005
Polymorphic variation of Cyp1A1 is associated with the risk of gastric cardia cancer: a prospective case-cohort study of cytochrome P-450 1A1 and GST enzymesMark J Roth, Christian C Abnet, Laura Lee Johnson, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Journal of Palliative Medicine|February 28, 2006
Accounting for missing data in end-of-life researchPaula Diehr, Laura Lee Johnson
Statistics in Medicine|March 7, 2012
The statistical challenges in clinical studies. PrefaceXiao-Hua Zhou, Laura Lee Johnson
Archives of Internal Medicine|September 20, 2006
Insomnia, trouble sleeping, and complementary and alternative medicine: Analysis of the 2002 national health interview survey dataNancy J Pearson, Laura Lee Johnson, Richard L Nahin
Journal of Clinical Epidemiology|October 15, 2005
Methods for incorporating death into health-related variables in longitudinal studiesPaula Diehr, Laura Lee Johnson, Donald L Patrick, et al.
Cancer|October 22, 2025
Assessing tolerability of cancer therapeutics: A regulatory perspective from the FDA Oncology Center of ExcellenceVishal Bhatnagar, Laura Lee Johnson, Mallorie H Fiero, et al.
The New England Journal of Medicine|November 3, 2020
Withdrawing Approval of Makena - A Proposal from the FDA Center for Drug Evaluation and ResearchChristina Y Chang, Christine P Nguyen, Barbara Wesley, et al.
Integrative Cancer Therapies|August 2, 2006
Tai chi chuan: mind-body practice or exercise intervention? Studying the benefit for cancer survivorsPatrick Mansky, Tim Sannes, Dawn Wallerstedt, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2005
Gene-specific methylation and subsequent risk of colorectal adenomas among participants of the polyp prevention trialKaren Woodson, Daniel J Weisenberger, Mihaela Campan, et al.
Genes, Chromosomes & Cancer|August 23, 2005
beta-Catenin splice variants and downstream targets as markers for neoplastic progression of esophageal cancerMark J Roth, Nan Hu, Laura Lee Johnson, et al.
Cancer Causes & Control : CCC|April 2, 2005
Polymorphic variation of Cyp1A1 is associated with the risk of gastric cardia cancer: a prospective case-cohort study of cytochrome P-450 1A1 and GST enzymesMark J Roth, Christian C Abnet, Laura Lee Johnson, et al.
Pageof 3